David Edward Clark

USPTO Granted Patents = 26 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 8.9

ph-index = 7

Forward Citations = 184(Granted Patents)

Location History:

Essex, GB (2008 - 2019)
Margate Kent, GB (2021)
Harlow, GB (2007 - 2023)

Company Filing History:

Corcept Therapeutics Incorporated

patents

3 out of 17

Helperby Therapeutics Limited

Janssen Pharmaceutica Nv

patents

7. 1 out of 4

Pharmagene Laboratories Limited

patents

8. 1 out of 23

Kalvista Pharmaceuticals Limited

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12286411 - Indane derivatives for use in the treatment of bacterial infection (2025-04-29),

2. 12247013 - Indane derivatives for use in the treatment of bacterial infection (2025-03-11),

3. 12227475 - Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditions (2025-02-18),

4. 11613527 - Enzyme inhibitors (2023-03-28),

5. 11000511 - Chemical compounds as antibiotics (2021-05-11),

6. 10493071 - Use of pyrroloquinoline compounds to kill clinically latent microorganisms (2019-12-03),

7. 10005773 - [object Object] (2018-06-26),

8. 9981963 - [object Object] (2018-05-29),

9. 9839623 - Tricyclic compounds and methods of making and using same (2017-12-12),

10. 9694006 - Use of pyrroloquinoline compounds to kill clinically latent microorganisms (2017-07-04),

11. 9266896 - Tricyclic compounds and methods of making and using same (2016-02-23),

12. 8324203 - Azadecalin glucocorticoid receptor modulators (2012-12-04),

13. 8207187 - Use of pyrroloquinoline compounds to kill clinically latent microorganisms (2012-06-26),

14. 8173664 - Modified pyrimidine glucocorticoid receptor modulators (2012-05-08),

15. 8080567 - [object Object] (2011-12-20),

Title: David Edward Clark - A Pioneer in Pharmaceutical Innovations

Introduction

David Edward Clark, based in Essex, GB, is a remarkable innovator with a portfolio of 24 patents to his name. His contributions to the pharmaceutical field have focused on developing novel compounds aimed at treating various medical conditions.

Latest Patents

Among his latest inventions are notable patents that include "Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditions" and "Enzyme inhibitors." The first invention details the development of aza-heterocyclyl carboxamide compounds, which have applications in treating medical conditions such as bacterial infections by inhibiting LpxC activity. The second patent introduces innovative compounds with therapeutic applications, particularly in treating diseases where plasma kallikrein activity is involved.

Career Highlights

David has worked with several prominent companies, including Asterand UK Limited and Corcept Therapeutics Incorporated. His experience in these organizations has allowed him to refine his expertise and contribute significantly to the development of pharmaceutical innovations.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as George Hynd and Jonathan Mark Sutton. These partnerships have fostered a dynamic environment for research and development, further enhancing the impact of their collective work in the pharmaceutical industry.

Conclusion

David Edward Clark's inventive spirit and dedication to improving medical treatments have solidified his reputation as a leading inventor in the field. With numerous patents and a commitment to innovation, he continues to make significant strides in pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.